The effect of interleukin 1 alpha on acetaminophen-induced hepatotoxicity

Cytokine. 1993 May;5(3):192-7. doi: 10.1016/1043-4666(93)90004-o.

Abstract

The protective effect of interleukin 1 alpha (IL-1 alpha) in mice with acetaminophen (AAP)-induced hepatitis was investigated. IL-1 alpha had a significant protective effect if given 2 or more hours (up to 24 hours) before AAP; it significantly reduced mortality of mice and decreased serum transaminase level. The maximal effect was obtained with the dose of 1000 U (166 ng/kg) IL-1 alpha. Pretreatment with IL-1 significantly increased the synthesis of prostaglandin E2 (PGE2) in samples of liver tissue from AAP-treated mice, but had no effect on the synthesis of leukotriene C4 (LTC4). Pretreatment with indomethacin (IMC) did not abrogate significantly the protective effect of IL-1. Thus, the hepatoprotective effect of IL-1 alpha can not be entirely explained by the stimulation of prostaglandin (PG) synthesis.

MeSH terms

  • Acetaminophen / toxicity*
  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • Dinoprostone / biosynthesis
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Hepatitis, Animal / chemically induced
  • Hepatitis, Animal / prevention & control*
  • Indomethacin / pharmacology
  • Interleukin-1 / administration & dosage
  • Interleukin-1 / pharmacology*
  • Interleukin-1 / therapeutic use
  • Leukotriene C4 / biosynthesis
  • Liver / drug effects*
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Mice
  • Mice, Inbred CBA

Substances

  • Interleukin-1
  • Leukotriene C4
  • Acetaminophen
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Dinoprostone
  • Indomethacin